Cochlear Limited · ASX:COH

Michael del Prado bought 235 Cochlear Limited shares (Appendix 3Y, ASX)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Michael del Prado (Director) bought 235 Cochlear Limited shares at US$102.26 for US$24,031. Filed Nov 18, 2026 (Appendix 3Y, ASX).

Bought
235 shares
Price
US$102.26
Value
US$24,031
Role
Director

The filing in full

*Rule 3.19A.2*

Appendix 3Y

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityCochlear Limited
ABN96 002 618 073

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.

Name of DirectorMichael del Prado
Date of last notice27 August 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.

Direct or indirect interestDirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Not applicable
Date of change16 November 2026
No. of securities held prior to change1,504 Shares
ClassFully Paid Ordinary Shares in Cochlear Limited (“Shares”)
Number acquired235 Shares
Number disposed-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuationUS$102.26 per Share
No. of securities held after change1,739 Shares

---

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backPurchase of Shares on the United States over-the-counter (OTC) market

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.

Detail of contractN/A
Nature of interestN/A
Name of registered holder (if issued securities)N/A
Date of changeN/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedN/A
Interest acquiredN/A
Interest disposedN/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuationN/A
Interest after changeN/A

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
If so, was prior written clearance provided to allow the trade to proceed during this period?N/A
If prior written clearance was provided, on what date was this provided?N/A
  • See chapter 19 for defined terms.
DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Fully Paid Ordinary Shares in Cochlear Limited (“Shares”)Buy235US$102.26

Source

Download PDF · View original at ASX

Related